|
|
Volumn 115, Issue 4, 2015, Pages 500-
|
|
Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
KALLIKREIN;
KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;
TUMOR MARKER;
BODY MASS;
CANCER EPIDEMIOLOGY;
DIAGNOSTIC VALUE;
EARLY DIAGNOSIS;
EDITORIAL;
FAMILY HISTORY;
HIGH RISK POPULATION;
HUMAN;
OBESITY;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
PROSTATE HEALTH INDEX;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
UROGENITAL TRACT DISEASE ASSESSMENT;
BLOOD;
MALE;
MEN'S HEALTH;
PATHOLOGY;
PROSTATE;
PROSTATIC NEOPLASMS;
SEVERITY OF ILLNESS INDEX;
HUMANS;
KALLIKREINS;
MALE;
MEN'S HEALTH;
PROSTATE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
SEVERITY OF ILLNESS INDEX;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84925673007
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/bju.12966 Document Type: Editorial |
|
Times cited : (9)
|
|
References (8)
|
